Global Direct-to-consumer Genetic Sequencing Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Direct-to-consumer Genetic Sequencing Market Research Report 2024
Direct-to-consumer genetic testing is differentthese genetic tests are marketed directly to customers via television, print advertisements, or the Internet, and the tests can be bought online or in stores. Customers send the company a DNA sample and receive their results directly from a secure website or in a written report. Direct-to-consumer genetic testing provides people access to their genetic information without necessarily involving a healthcare provider or health insurance company in the process.
According to MRAResearch’s new survey, global Direct-to-consumer Genetic Sequencing market is projected to reach US$ 1930.9 million in 2033, increasing from US$ 1025 million in 2022, with the CAGR of 9.3% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Direct-to-consumer Genetic Sequencing market research.
The increasing incidence of genetic disorders and hereditary diseases has led to a greater demand for genetic testing and gene sequencing services for diagnosis and risk assessment.
Gene sequencing is widely used in cancer research to identify specific genetic mutations and biomarkers associated with different cancer types, aiding in the development of targeted therapies.
The popularity of DTC genetic testing services, which provide individuals with personalized genetic information, has contributed to the growth of the gene sequencing service market.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Direct-to-consumer Genetic Sequencing market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
23andMe
MyHeritage
LabCorp
Myriad Genetics
Ancestry.com
Quest Diagnostics
Gene By Gene
DNA Diagnostics Center
Invitae
IntelliGenetics
Ambry Genetics
Living DNA
EasyDNA
Pathway Genomics
Centrillion Technology
Xcode
Color Genomics
Anglia DNA Services
African Ancestry
Canadian DNA Services
DNA Family Check
Alpha Biolaboratories
Test Me DNA
23 Mofang
Genetic Health
DNA Services of America
Shuwen Health Sciences
Mapmygenome
Full Genomes
Segment by Type
Diagnostic Screening
PGD Relationship Testing
Online
Offline
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Direct-to-consumer Genetic Sequencing report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to MRAResearch’s new survey, global Direct-to-consumer Genetic Sequencing market is projected to reach US$ 1930.9 million in 2033, increasing from US$ 1025 million in 2022, with the CAGR of 9.3% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Direct-to-consumer Genetic Sequencing market research.
The increasing incidence of genetic disorders and hereditary diseases has led to a greater demand for genetic testing and gene sequencing services for diagnosis and risk assessment.
Gene sequencing is widely used in cancer research to identify specific genetic mutations and biomarkers associated with different cancer types, aiding in the development of targeted therapies.
The popularity of DTC genetic testing services, which provide individuals with personalized genetic information, has contributed to the growth of the gene sequencing service market.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Direct-to-consumer Genetic Sequencing market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
23andMe
MyHeritage
LabCorp
Myriad Genetics
Ancestry.com
Quest Diagnostics
Gene By Gene
DNA Diagnostics Center
Invitae
IntelliGenetics
Ambry Genetics
Living DNA
EasyDNA
Pathway Genomics
Centrillion Technology
Xcode
Color Genomics
Anglia DNA Services
African Ancestry
Canadian DNA Services
DNA Family Check
Alpha Biolaboratories
Test Me DNA
23 Mofang
Genetic Health
DNA Services of America
Shuwen Health Sciences
Mapmygenome
Full Genomes
Segment by Type
Diagnostic Screening
PGD Relationship Testing
Segment by Application
Online
Offline
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Direct-to-consumer Genetic Sequencing report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source